MALDI, LC/TOF, Software, LC/MS
IndustriesPharma & Biopharma
ManufacturerShimadzu
Significance of the topic
The accurate identification of pathogenic and environmental Acinetobacter species is critical due to rising antibiotic resistance and the complexity of the ACB complex.
Objectives and Study Overview
This study evaluates the ability of the cloud-based MicrobialTrack software to distinguish four species in the ACB complex (A. baumannii, A. calcoaceticus, A. nosocomialis, A. pittii) using MALDI-TOF mass spectrometry.
Methodology
Thirty-three strains were cultured on heart infusion agar and prepared by formic acid extraction and CHCA matrix application. Spectra were acquired on a MALDI-TOF MS AXIMA Performance in linear positive mode (m/z 2 000–20 000). Data were analyzed with MicrobialTrack using two genomic databases (“All” and representative “Reps”) and a default peak threshold of 0.0002.
Used Instrumentation
- AXIMA Performance MALDI-TOF mass spectrometer (Shimadzu)
- MicrobialTrack cloud-based identification software
Main Results and Discussion
Out of 159 spectra, 156 (98.1 %) were classified as “Very High” reliability, matching reference strain names at 98.7 %. Species-specific peaks, notably ribosomal proteins, were annotated by comparing measured masses to genome-predicted values, enabling clear discrimination within the ACB complex. Three spectra with fewer peaks were flagged as “Low” reliability and require further inspection.
Benefits and Practical Applications
- High-resolution species identification, even for closely related taxa
- Rich spectral annotation informed by genomic data
- Cloud-based platform eliminates the need for local software installation
Future Trends and Opportunities
Expanding genomic reference databases, integration of artificial intelligence for spectral interpretation, and real-time clinical deployment will further enhance microbial diagnostics across healthcare, food safety, and environmental monitoring.
Conclusion
MicrobialTrack leverages genome-derived protein mass predictions to deliver robust, high-confidence identification of Acinetobacter species within the challenging ACB complex, overcoming limitations of conventional MALDI-TOF MS methods.
References
- Nithichanon A, et al. Acinetobacter nosocomialis causes as severe disease as Acinetobacter baumannii in Northeast Thailand. Microbiol Spectr. 2022;10(6):e02836-22.
- Sekiguchi Y, et al. A large-scale genomically predicted protein mass database enables rapid and broad-spectrum identification of bacterial and archaeal isolates by mass spectrometry. Genome Biol. 2023;24:257.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.